EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baicalein combined with azoles against fungi in vitro

Mengmin Liang, Qingwen Hu, Junhao Yu, Heng Zhang, Sijie Liu, Jiangrong Huang, Yi Sun

Frontiers in Microbiology · 13.03.2025 · 16

DOI: 10.3389/fmicb.2025.1537229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.03.2025. Verfasst von Mengmin Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections (IFIs) constitute a significant health challenge, particularly among immunocompromised individuals, characterized by a high prevalence and associated mortality rates. The synergistic administration of Baicalein (BE) with azole antifungal agents could potentially herald a novel therapeutic paradigm. Materials and methods 54 Aspergillus strains and 23 strains of dematiaceous fungi were selected. The standard M38-A2 microbroth dilution method was used to test the minimum inhibitory concentration (MIC) and the fractional inhibitory concentration index (FICI) of fungi when BE combined with itraconazole (ITC), voriconazole (VRC), posaconazole (POS) and Isavuconazole (ISV).

Results

BE shows synergistic effects with POS and ITC, with 89.61% and 25.97% of fungal strains. The BE/POS regimen exerted synergistic effects in 87.04% of Aspergillus and an impressive 95.65% of dematiaceous fungi. In comparison, the BE/ITC combination showed significantly lower synergy, affecting 33.33% of Aspergillus and a mere 8.70% of dematiaceous strains. Antagonistic interactions were sporadically observed with BE in combination with ITC, VRC, POS and ISV. Within the azole class, the BE/POS pairing stood out for its frequent synergistic activity, in contrast to the absence of such effects when BE was paired with VRC or ISV. Highlighting the potential of BE/POS as a notably effective antifungal strategy.

Conclusion

In vitro , BE/POS combination emerged as the most effective antifungal strategy, exhibiting synergistic effects in the majority of Aspergillus and dematiaceous fungi strains, whereas BE/ITC showed significantly less synergy, and BE with VRC or ISV displayed no synergistic activity.

Schlagwörter

Stichwörter der Autor:innen

Aspergillusbaicaleindematiaceous fungiitraconazoleposaconazolesynergy

Autor:innen und Institutionen

  • School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Department of Clinical Medicine, Yangtze University, Jingzhou, China.
  • Department of Dermatology, Jingzhou Hospital Affiliated to Yangtze University, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou, China.
  • Endocrinology Department, The Third Clinical College of Yangtze University, Traditional Chinese Medicine of Jingzhou Hospital, Jingzhou, China.

Zitieren

APA

Liang, M., Hu, Q., Yu, J., Zhang, H., Liu, S., Huang, J., & Sun, Y. (2025). Baicalein combined with azoles against fungi in vitro. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1537229

Vancouver

Liang M, Hu Q, Yu J, Zhang H, Liu S, Huang J, et al. Baicalein combined with azoles against fungi in vitro. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1537229

BibTeX
@article{Liang2025,
  author = {Liang, Mengmin and Hu, Qingwen and Yu, Junhao and Zhang, Heng and Liu, Sijie and Huang, Jiangrong and Sun, Yi},
  title = {Baicalein combined with azoles against fungi in vitro},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1537229}
}
Kostenlos starten →